The Global Antibiotic Research & Development Partnership (GARDP) is a not-for-profit research and development organization, committed to developing and delivering five new treatments to address antibiotic resistant infections by 2025. Initiated by the World Health Organization and Drugs for Neglected Disease initiative, GARDP is an important element of the WHO’s Global Action Plan on Antimicrobial Resistance.
GARDP, through REVIVE, is supporting the antimicrobial R&D community to champion a new generation of antibiotic researchers. As well as developing internally and externally authored blogs and gathering a team of experts dedicated to answering emerging questions in the field, we also regularly host webinars on relevant topics.
This webinar follows on from William J. Weiss from the University of North Texas who presented on the use of in vivo models for infectious disease research in June 2019. In his webinar, William introduced the experimental design of animal models for antimicrobial research, and discussed whether animal models for bacterial infections reflect clinical conditions. As well as if they can be predictive of clinical efficacy. Watch the recording of this webinar now, along with any others you may have missed.
Our next webinar focuses on in vivo models for infectious disease research with Peter Warn, Senior Vice President from Evotec. Peter will review the experimental design and conduct of advanced and complex animal models for antimicrobial research, such as models of pneumonia, UTI and tissue infections. Click here to register for this upcoming webinar.